Since its inception in 1971 Sinclair Pharma has strived to improve the health, appearance and confidence of patients, whilst creating value for healthcare providers and shareholders. From a historical base in dermatology, Sinclair has become focused on facial aesthetics through a number of strategic acquisitions. Corporate headquarters is based in London and commercial headquarters in Paris. The company has an established sales and marketing footprint in the; UK, France, Germany, Italy and Spain, and a rapidly-growing presence in emerging markets around the world through key strategic partners.

Sinclair Pharma plc is listed on the London Stock Exchange AIM market